171 related articles for article (PubMed ID: 30337802)
1. Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model.
Kim D; Kwon S; Jeon H; Ryu S; Ha KT; Kim S
J Ginseng Res; 2018 Oct; 42(4):429-435. PubMed ID: 30337802
[TBL] [Abstract][Full Text] [Related]
2. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon.
Jeon H; Bae CH; Lee Y; Kim HY; Kim S
Brain Behav Immun; 2021 May; 94():410-423. PubMed ID: 33662500
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.
Kim D; Jeon H; Ryu S; Koo S; Ha KT; Kim S
PLoS One; 2016; 11(10):e0164906. PubMed ID: 27788166
[TBL] [Abstract][Full Text] [Related]
4. Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model.
Jun YL; Bae CH; Kim D; Koo S; Kim S
J Ginseng Res; 2015 Apr; 39(2):148-54. PubMed ID: 26045688
[TBL] [Abstract][Full Text] [Related]
5. Korean Red Ginseng Enhances Neurogenesis in the Subventricular Zone of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice.
Ryu S; Jeon H; Koo S; Kim S
Front Aging Neurosci; 2018; 10():355. PubMed ID: 30459594
[TBL] [Abstract][Full Text] [Related]
6. Korean Red Ginseng Regulates Intestinal Tight Junction and Inflammation in the Colon of a Parkinson's Disease Mouse Model.
Jeon H; Kim HY; Bae CH; Lee Y; Kim S
J Med Food; 2020 Dec; 23(12):1231-1237. PubMed ID: 33121350
[TBL] [Abstract][Full Text] [Related]
7. Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson's disease.
Parlak H; Ozkan A; Dilmac S; Tanriover G; Ozsoy O; Agar A
Folia Histochem Cytobiol; 2018; 56(1):27-37. PubMed ID: 29577226
[TBL] [Abstract][Full Text] [Related]
8. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
10. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
13. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
[TBL] [Abstract][Full Text] [Related]
14. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
15. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
Watanabe Y; Kato H; Araki T
Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
[TBL] [Abstract][Full Text] [Related]
16. RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
Dutta D; Kundu M; Mondal S; Roy A; Ruehl S; Hall DA; Pahan K
Neurobiol Dis; 2019 Dec; 132():104575. PubMed ID: 31445159
[TBL] [Abstract][Full Text] [Related]
17. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease in mice.
Liu H; Wu H; Zhu N; Xu Z; Wang Y; Qu Y; Wang J
J Neurochem; 2020 Feb; 152(3):397-415. PubMed ID: 31442326
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
20. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
